РОССИЙСКАЯ АКАДЕМИЯ НАУК УРАЛЬСКОЕ ОТДЕЛЕНИЕ ИНСТИТУТ ХИМИИ TBEPДОГО ТЕЛА |
|
|
14.05.2008 | Карта сайта Language |
|
The researchers adopted a two-pronged attack to solve the problem. Firstly, they engineered their yeast so that it could make a key molecule involved in UAA manufacture, bacterial transfer RNA, much more efficiently. Then they removed some of the yeast's cellular error-detection machinery. This normally stops yeast from producing UAA-containing proteins by breaking down 'foreign' messenger RNA carrying genetic information from the nucleus to the ribosome, the cell's protein factory. 'The result is that by using these two approaches we have increased by 300 times the amount of protein containing the UAA that can be obtained from yeast cells. These are quantities that are useful if you need to purify the proteins for therapeutic or industrial purposes,' says Wang. The team managed to produce proteins containing two different UAAs - DanAla and OmeTyr. Thomas Magliery, a protein expert at Ohio State University in the US, says, 'This is an interesting biotechnological advance because it suggests a way to produce proteins containing unnatural amino acids in process-scale quantities directly from eukaryotic cells and therefore with modifications which may be critical to function, stability or immune response.' The use of UAAs as probes has been limited because eukaryotes don't produce proteins containing them in large enough quantities, Magliery says. 'The approaches described here will potentially remove that limitation for a wide range of chemical biology experiments in yeast and mammalian cells,' he adds.
Simon Hadlington
Interesting? Spread the word using the 'tools' menu on the left. ReferencesQ Wang and L Wang, J. Am. Chem. Soc., 2008, 130, 6066 (DOI:
|
|
|
|
|
|||||||